Key facts
- It has raised $8.4M; the latest was Seed Round ($6.2M) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Mallia Innovations
- ·The full record, as it builds
Funding rounds
No funding rounds for Mallia Innovations are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mallia Innovations
Developer of a biopharmaceutical therapy intended to treat patients suffering from hair loss. The company uses a human immune-modulating protein, to induce hair growth via a dual mode of action, by activating the growth of existing hair via regulatory T cells at the hair follicle and by inducing the formation of new hair follicles via direct action on follicular stem cells, enabling companies to develop an effective and safe tropical treatment for hair loss, targeting a large and growing market.
- Sector
- Healthcare
- HQ
- Erlangen, Germany
- Founded
- 2023
- Employees
- 5
- Website
- mallia.com/
- Ownership
- Privately Held (backing)
Mallia Innovations doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mallia Innovations shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mallia Innovations in its N-PORT filings yet. We sweep new filings monthly.